Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.: Kelun-Biotech Announces Phase III Trial of Sac-TMT in Combination with KEYTRUDA (pembrolizumab) as First-Line Treatment for ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company", 6990.HK) announced today that the Independent Data ...

Soulpower Acquisition Corp.: Soulpower Acquisition Corporation (NYSE:SOUL) Announces Signing of Business Combination Agreement for Business Combination with SWB LLC Currently ...

Soulpower Acquisition Corporation (NYSE:SOUL) ("Soulpower") announced today that it has entered into a definitive business combination agreement (the "BCA") ...

Lotus Technology Inc.: Lotus Technology Reports Unaudited Third Quarter and First Nine Months 2025 Financial Results

Delivered 4,612 vehicles1 and achieved total revenue of $356 million in first nine months of 2025.Gross margin improved to 8% in the third quarter, reflecting healthier inventory dynamics and continue ...

Saarstahl übernimmt niederländischen Langstahlhersteller FNsteel

VÖLKLINGEN (dpa-AFX) - Saarstahl übernimmt den niederländischen Langstahlhersteller FNsteel. Das Unternehmen mit Sitz in Alblasserdam habe sich vor allem auf die Herstellung von hochwertigen Kaltstauc ...

Mike Lindell Media Corp. (MLMC) and LindellTV Announce New Chief Pentagon Reporter

Mike Lindell Media Corp. announces the latest stellar addition to their winning news division, welcoming Chief Pentagon Correspondent, Heather Mullins.

Genprex, Inc.: Data from Genprex's Acclaim-1 Phase 1 Gene Therapy Clinical Trial Published in Clinical Lung Cancer

Phase 1 Study in Non-Small Cell Lung Cancer Combined Reqorsa® Gene Therapy with Tagrisso® AUSTIN, Texas, Nov. 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or ...

Harley-Davidson, Inc.: Harley-Davidson Financial Services, Inc. Announces Results of Tender Offers for Any and All of its Outstanding 6.500% Medium-Term Notes due 2028 and 5. ...

Harley-Davidson Financial Services, Inc. (the "Company" or "HDFS"), a subsidiary of Harley-Davidson, Inc., today announced ...

Alvotech Announces Approval of AVT03, a Biosimilar to Prolia and Xgeva (denosumab) in the European Economic Area

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide ...

OVHcloud and LCH SA sign cloud agreement

Roubaix - November 20th 2025 - OVHcloud, a global cloud player and the European Cloud leader, announced today that it has signed a cloud hosting agreement with LCH SA, the global clearing house based ...

Thunderful Group AB: Thunderful Group Initiates Restructuring in its Co-Development Segment

The Board of Directors of Thunderful Group (publ) has today decided to initiate a restructuring program within the co-development segment, to balance operational expenses with current contracted ...

Clean Air Metals reicht technischen Bericht zur vorläufigen wirtschaftlichen Bewertung für das Projekt "Thunder Bay North Critical Minerals" ein

THUNDER BAY, ON / ACCESS Newswire / 24. November 2025 / Clean Air Metals Inc. ("Clean Air Metals" oder das "Unternehmen") (TSXV:AIR)(FRA:CKU)(OTCQB:CLRMF) freut sich bekannt zu geben, dass es die ...

InspireMD Inc.: Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting

InspireMD, Inc. (Nasdaq: NSPR) ("InspireMD" or the "Company"), developer of the CGuard- Prime carotid stent system for the prevention of stroke, welcomes the ...